Your Article Summary
See Latest ArticlesDistinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction
European Heart Journal, 06/05/09
Hamdani N et al. – Myocardial effects unique to either heart failure (HF) with normal left ventricular ejection fraction (LVEF) (HFNEF) or HF with reduced LVEF (HFREF) may contribute to the dissimilar outcome of beta-blocker therapy in both HF phenotypes.
Methods- Study of whether beta-blockers have distinct myocardial effects in HFNEF and HFREF, myocardial structure, cardiomyocyte function, and myocardial protein composition in HFNEF and HFREF pts with/without beta-blockers free of coronary artery disease
- Pt classification: 16 beta-HFNEF, 16 beta+HFNEF, 17 beta-HFREF, 22 beta+HFREF
- LV endomyocardial biopsies for collagen volume fraction (CVF) and cardiomyocyte diameter (MyD) by histomorphometry, phosphorylation of myofilamentary proteins by ProQ-Diamond phosphostained 1D-gels, and expression of beta-adrenergic signalling and calcium handling proteins by western immunoblotting
- Cardiomyocytes isolated from biopsies to measure active force (Factive), resting force (Fpassive), and calcium sensitivity (pCa50)
- Myocardial effects of beta-blocker therapy either shared by HFNEF and HFREF, unique to HFNEF or unique to HFREF
- Shared: higher Factive, higher pCa50, lower phosphorylation of troponin I and myosin-binding protein C, and lower beta-2 adrenergic receptor expression
- Unique to HFNEF: higher Fpassive, lower CVF, lower MyD, and lower expression of stimulatory G protein
- Unique to HFREF: lower expression of inhibitory G protein
Related Articles
Is Pretreatment with Beta-Blockers Beneficial in Patients with Acute Coronary Syndrome
Cardiology, 11/13/09
Relevance Score: 65%
Use of Combination Therapy with a beta-Blocker and Milrinone in Patients with Advanced Heart Failure
Annals of Pharmacotherapy, 10/13/09
Relevance Score: 65%
Management of hypertension in the elderly patient
Clinical Interventions in Aging, 10/01/09
Relevance Score: 65%
Respiratory Effects of beta-blocker Therapy in Heart Failure
Cardiovascular Drugs and Therapy, 10/06/09
Relevance Score: 64%
Pharmacodynamic Interactions with Exercise and Beta-Blocker Medications
American Journal of Lifestyle Medicine, 11/16/09
Relevance Score: 63%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
How do providers assess antihypertensive medication adherence in medical encounters?
Journal of General Internal Medicine, 12/18/09
Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review
The American Journal of Geriatric Pharmacotherapy, 12/18/09
Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/18/09
Today in Heart Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost of treating heart failure in an Irish teaching hospital
Irish Journal of Medical Science, 12/18/09
Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure
International Journal of Cardiology, 12/15/09
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition
International Journal of Cardiology, 12/14/09
Today in Myocardium/Pericardium...keeping you current
Receive free subspecialty "5-minute updates" via email
Right ventricular systolic function and cardiac resynchronization therapy
Europace, 12/18/09
Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy
The American Journal of Cardiology, 12/18/09
Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy
Europace, 12/18/09
Today in Physiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner
Cardiovascular Research, 12/18/09
Spontaneously beating cardiomyocytes derived from white mature adipocytes
Cardiovascular Research, 12/18/09
The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions
Cardiovascular Research, 12/18/09